Why the study?
Although cardiac rehabilitation is guideline-recommended and reduces morbidity and mortality in heart failure, it remains underutilized in clinical practice with worldwide participation rates of only 14% to 43%.
Does cardiac rehabilitation including exercise training improve functional capacity, quality of life, and mortality in patients with heart failure?
Does cardiac rehabilitation including exercise training improve functional capacity, quality of life, and mortality in patients with heart failure?
Despite strong guideline recommendations and proven benefits for mortality and quality of life, cardiac rehabilitation remains severely underutilized in heart failure patients worldwide.
Cardiac rehabilitation remains underused in heart failure despite benefits; leaves open optimal strategies to boost global participation.
Heart failure (HF) is a complex clinical syndrome caused by a structural and/or functional cardiac abnormality, resulting in reduced organ perfusion. The goals of treatment in patients with HF are to improve functional capacity and quality of life, and to reduce mortality. Cardiac rehabilitation (CR) including exercise training is one of the treatment options, and current guidelines recommend CR as safe and effective for patients with HF. CR has been known to improve exercise capacity and quality of life, minimize HF progression, and lower mortality in patients with HF. Improvement of vascular endothelial function, activation of the neurohormonal system, increase of mitochondrial oxygen utilization in peripheral muscles, and increase of chronotropic responses are possible mechanisms of the beneficial effects of exercise-based CR in HF. Although CR has been shown to decrease morbidity and mortality, it is underutilized in clinical practice. Despite the existence of concrete evidence of clinical benefits, the CR participation rates of patients with HF range from only 14% to 43% worldwide, with high dropout rates after enrollment. These low participation rates have been attributed to several barriers, including patient factors, professional factors, and service factors. The motivation for participating in CR and for overcoming the patients' barriers for CR before discharge should be provided to each patient. Current guidelines strongly recommend applying a CR program to all eligible patients with HF.
No takes yet. Share an insight, caveat, or question.
Chun et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: